237 related articles for article (PubMed ID: 8681572)
1. Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes.
Murakami K; Okajima K; Uchiba M; Okabe H; Takatsuki K
Crit Care Med; 1996 Jun; 24(6):1047-53. PubMed ID: 8681572
[TBL] [Abstract][Full Text] [Related]
2. Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation.
Harada N; Okajima K; Kushimoto S
Crit Care Med; 1999 Sep; 27(9):1958-64. PubMed ID: 10507625
[TBL] [Abstract][Full Text] [Related]
3. Gabexate mesilate, a synthetic protease inhibitor, prevents compression-induced spinal cord injury by inhibiting activation of leukocytes in rats.
Taoka Y; Okajima K; Uchiba M; Murakami K; Kushimoto S; Johno M; Naruo M; Okabe H; Takatsuki K
Crit Care Med; 1997 May; 25(5):874-9. PubMed ID: 9187610
[TBL] [Abstract][Full Text] [Related]
4. Gabexate mesilate, a synthetic anticoagulant, inhibits the expression of endothelial leukocyte adhesion molecules in vitro.
Uchiba M; Okajima K; Kaun C; Binder BR; Wojta J
Crit Care Med; 2003 Apr; 31(4):1147-53. PubMed ID: 12682486
[TBL] [Abstract][Full Text] [Related]
5. Gabexate mesilate, a synthetic protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappaB and activator protein-1 in human monocytes.
Yuksel M; Okajima K; Uchiba M; Okabe H
J Pharmacol Exp Ther; 2003 Apr; 305(1):298-305. PubMed ID: 12649382
[TBL] [Abstract][Full Text] [Related]
6. Effects of gabexate mesilate on coagulopathy and organ dysfunction in rats with endotoxemia: a potential use of thrombelastography in endotoxin-induced sepsis.
Tsai HJ; Ding C; Tsao CM; Liao MH; Ka SM; Liaw WJ; Wu CC
Blood Coagul Fibrinolysis; 2015 Mar; 26(2):175-84. PubMed ID: 25396762
[TBL] [Abstract][Full Text] [Related]
7. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats.
Murakami K; Okajima K; Uchiba M; Johno M; Nakagaki T; Okabe H; Takatsuki K
Blood; 1996 Jan; 87(2):642-7. PubMed ID: 8555486
[TBL] [Abstract][Full Text] [Related]
8. Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats.
Mikami K; Goto T; Miura K; Ohshima S; Yoneyama K; Lin JG; Watanabe D; Segawa D; Kataoka E; Shibuya T; Watanabe S
J Gastroenterol; 2005 Mar; 40(3):260-5. PubMed ID: 15830285
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats.
Uchiba M; Okajima K; Murakami K; Okabe H; Takatsuki K
Thromb Res; 1995 Apr; 78(2):117-25. PubMed ID: 7482429
[TBL] [Abstract][Full Text] [Related]
10. Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury.
Hidaka S; Iwasaka H; Hagiwara S; Noguchi T
J Surg Res; 2011 Jan; 165(1):142-50. PubMed ID: 19766246
[TBL] [Abstract][Full Text] [Related]
11. Effects of a synthetic protease inhibitor (gabexate mesilate) and a neutrophil elastase inhibitor (sivelestat sodium) on acid-induced lung injury in rats.
Yoshikawa S; Tsushima K; Koizumi T; Kubo K
Eur J Pharmacol; 2010 Sep; 641(2-3):220-5. PubMed ID: 20542026
[TBL] [Abstract][Full Text] [Related]
12. Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats.
Uchiba M; Okajima K; Murakami K; Okabe H; Takatsuki K
Am J Respir Crit Care Med; 1997 Feb; 155(2):711-8. PubMed ID: 9032217
[TBL] [Abstract][Full Text] [Related]
13. Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs.
Luh SP; Tsai CC; Shau WY; Chen JS; Kuo SH; Lin-Shiau SY; Lee YC
J Surg Res; 1999 Dec; 87(2):152-63. PubMed ID: 10600344
[TBL] [Abstract][Full Text] [Related]
14. Microcirculatory disturbances in endotoxin-induced disseminated intravascular coagulation. The effects of heparin and gabexate mesilate on locomotive and metabolic changes of neutrophils.
Suzuki M; Suematsu M; Miura S; Oshio C; Oda M; Tsuchiya M
Adv Exp Med Biol; 1988; 242():135-41. PubMed ID: 3149869
[TBL] [Abstract][Full Text] [Related]
15. The prevention of lipopolysaccharide-induced pulmonary vascular injury by pretreatment with cepharanthine in rats.
Murakami K; Okajima K; Uchiba M
Am J Respir Crit Care Med; 2000 Jan; 161(1):57-63. PubMed ID: 10619798
[TBL] [Abstract][Full Text] [Related]
16. [Antioxidant action of gabexate mesilate (Foy) in an experimental model of endotoxic shock].
Novelli GP; Casali R; Bonizzoli M; Giorgi L; Lemma M; Piscitelli P
Minerva Anestesiol; 1995 Dec; 61(12):509-13. PubMed ID: 8919988
[TBL] [Abstract][Full Text] [Related]
17. Effects of a protease inhibitor on reduction of surgical stress in esophagectomy.
Ono S; Aosasa S; Mochizuki H
Am J Surg; 1999 Jan; 177(1):78-82. PubMed ID: 10037314
[TBL] [Abstract][Full Text] [Related]
18. Effects of a neutrophil elastase inhibitor (ONO-5046) on acute pulmonary injury induced by tumor necrosis factor alpha (TNFalpha) and activated neutrophils in isolated perfused rabbit lungs.
Miyazaki Y; Inoue T; Kyi M; Sawada M; Miyake S; Yoshizawa Y
Am J Respir Crit Care Med; 1998 Jan; 157(1):89-94. PubMed ID: 9445283
[TBL] [Abstract][Full Text] [Related]
19. Differential cytokine response in host defence mechanisms triggered by gram-negative and gram-positive bacteria, and the roles of gabexate mesilate, a synthetic protease inhibitor.
Iwadou H; Morimoto Y; Iwagaki H; Sinoura S; Chouda Y; Kodama M; Yoshioka T; Saito S; Yagi T; Tanaka N
J Int Med Res; 2002; 30(2):99-108. PubMed ID: 12025532
[TBL] [Abstract][Full Text] [Related]
20. Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway.
Yoshinari D; Takeyoshi I; Koibuchi Y; Matsumoto K; Kawashima Y; Koyama T; Ohwada S; Morishita Y
Crit Care Med; 2001 Mar; 29(3):628-34. PubMed ID: 11373433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
